Morgan Stanley’s CytRx Corp CYTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,123
| Closed | -$3K | – | 6945 |
|
|
2019
Q1 | $3K | Buy |
5,123
+2,677
| +109% | +$1.68K | ﹤0.01% | 6432 |
|
|
2018
Q4 | $1K | Sell |
2,446
-298
| -11% | -$206 | ﹤0.01% | 6565 |
|
|
2018
Q3 | $2K | Sell |
2,744
-1,104
| -29% | -$1.25K | ﹤0.01% | 6604 |
|
|
2018
Q2 | $5K | Sell |
3,848
-6,182
| -62% | -$9.24K | ﹤0.01% | 6457 |
|
|
2018
Q1 | $16K | Buy |
10,030
+9,643
| +2,492% | +$17K | ﹤0.01% | 6184 |
|
|
2017
Q4 | $1K | Sell |
387
-652
| -63% | -$1.35K | ﹤0.01% | 6542 |
|
|
2017
Q3 | $2K | Sell |
1,039
-35,087
| -97% | -$119K | ﹤0.01% | 6423 |
|
|
2017
Q2 | $135K | Sell |
36,126
-3,587
| -9% | -$12.3K | ﹤0.01% | 5513 |
|
|
2017
Q1 | $106K | Sell |
39,713
-26,579
| -40% | -$67.3K | ﹤0.01% | 5581 |
|
|
2016
Q4 | $147K | Buy |
66,292
+44,456
| +204% | +$131K | ﹤0.01% | 5453 |
|
|
2016
Q3 | $77K | Buy |
21,836
+14,559
| +200% | +$66.7K | ﹤0.01% | 5416 |
|
|
2016
Q2 | $97K | Sell |
7,277
-2,562
| -26% | -$42.6K | ﹤0.01% | 5256 |
|
|
2016
Q1 | $158K | Sell |
9,839
-31
| -0.3% | -$424 | ﹤0.01% | 5105 |
|
|
2015
Q4 | $156K | Buy |
9,870
+1,641
| +20% | +$28.1K | ﹤0.01% | 5205 |
|
|
2015
Q3 | $117K | Sell |
8,229
-4,786
| -37% | -$81.1K | ﹤0.01% | 5349 |
|
|
2015
Q2 | $291K | Sell |
13,015
-3,901
| -23% | -$97.7K | ﹤0.01% | 5053 |
|
|
2015
Q1 | $342K | Sell |
16,916
-11,262
| -40% | -$210K | ﹤0.01% | 4898 |
|
|
2014
Q4 | $463K | Buy |
28,178
+4,678
| +20% | +$73K | ﹤0.01% | 4709 |
|
|
2014
Q3 | $358K | Buy |
23,500
+8,178
| +53% | +$162K | ﹤0.01% | 4791 |
|
|
2014
Q2 | $384K | Sell |
15,322
-19,117
| -56% | -$436K | ﹤0.01% | 4764 |
|
|
2014
Q1 | $722K | Buy |
34,439
+27,729
| +413% | +$984K | ﹤0.01% | 4277 |
|
|
2013
Q4 | $252K | Buy |
+6,710
| New | +$122K | ﹤0.01% | 4909 |
|
Other funds holding CYTR
Morgan Stanley's CYTR Position: Q2 2019 in Review
Morgan Stanley sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 5,123 shares — an estimated $3K sold.
Morgan Stanley first reported a position in CYTR in Q4 2013 and held it in 22 quarters. The position peaked at $722K in Q1 2014. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.
- Morgan Stanley reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
- Morgan Stanley sold 5,123 CytRx Corp shares in Q2 2019, an estimated $3K.
- Morgan Stanley first reported a position in CytRx Corp in Q4 2013 and held it in 22 quarters.
- Morgan Stanley's CytRx Corp position peaked at $722K in Q1 2014.
- 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.
Based on Morgan Stanley's 13F filing for Q2 2019, filed 14 Aug 2019.